As more manufacturers based in developing countries enter the market with prequalified vaccines, the increased choices they bring provides a more diversified supply base. It also increases competition in vaccine markets, often resulting in reduced prices.
In 2001, five manufacturers supplied vaccines to Gavi; just one of these was based in Africa. By 2017, nearly two thirds of our vaccine suppliers were based in Africa, Asia or Latin America.
The Vaccine Alliance has assigned a seat on its Board to a representative of the Developing Countries Vaccine Manufacturing Network (DCVMN), a voluntary alliance of 44 companies from 16 developing countries.
DCVMN's goals are closely aligned to those of Gavi and include:
From other sites